ELA Games has taken another strategic step in expanding its European footprint by partnering with Stake.dk, a newly regulated operator in Denmark’s evolving iGaming landscape.
News in Focus


PL Capital has reiterated an “Accumulate” recommendation on Elgi Equipments with a target price of Rs603, compared with the current market price of around Rs541.

Motilal Oswal Financial Services has reiterated a BUY recommendation on UltraTech Cement, highlighting the company’s continued market share expansion, disciplined capacity growth strategy, and impr

PL Capital (Prabhudas Lilladher) has reiterated an “Accumulate” recommendation on Kansai Nerolac Paints (KNPL) with a target price of Rs248, compared with the current market price of around Rs200.

Fortis Healthcare Limited continues to demonstrate robust operational and financial momentum, driven by sustained growth in its hospital segment and a steady recovery in its diagnostics arm, Agilus

ICICI Securities has reiterated a BUY rating on Coal India Ltd with a target price of Rs 500, implying an upside potential of roughly 18% from the current market price of Rs 425.
Main Regional Stories

India’s online betting ecosystem has evolved into one of the most dynamic digital gaming markets in the world, fueled by the country’s deep-rooted passion for cricket, the explosion of smartphone usage, and the rapid expansion of digital payment i

Online gambling and sports betting have evolved into a sprawling, technology-driven global industry valued in the billions, reshaping how consumers interact with gaming and wagering platforms.

The rise of prediction-based gaming platforms across Asia has created a new digital gambling frontier, with 91 Club emerging as one of the most widely discussed examples.

As our parents age, our primary concern often shifts from our own milestones to their well-being.
After touching an intraday high of 15,683.03 and low of 15,524.68, the BSE Sensex finally settled at 15,565.55 after making a gain of 15.42 points, whereas the broad-based NSE Nifty ended at 4,566.05, up 3.95 points.
Today, fertiliser scrips commanded the gainer
or the first quarter ended June 2007, Pune-based Tech Mahindra’s conso
New Delhi: Actuated by maturation in key emerging markets, India’s leading pharmaceutical company Ranbaxy Laboratories’ net profit for the quarter ended June 30 climbed up 118 percent to Rs 266.2 crore from Rs 122.11 crore in the corresponding period of the last year. 








